SCHEMBL8338997

SCHEMBL8338997

NC(N)=NC(=O)c1ccn(-c2ccnc3c(F)cccc23)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR5A P47898 10/20 0.41
SLC9A1 P19634 4/20 0.37
HTR7 P34969 1/20 0.36
HTR2B P41595 1/20 0.36
KDM4E B2RXH2 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
CDC7 O00311 1/20 0.34
AURKA O14965 1/20 0.34
PRKD3 O94806 1/20 0.34
MAP4K4 O95819 1/20 0.34
CDK1 P06493 1/20 0.34
CSF1R P07333 1/20 0.34
CDK2 P24941 1/20 0.34
MAPK1 P28482 1/20 0.34
FLT4 P35916 1/20 0.34
KDR P35968 1/20 0.34
CSNK1D P48730 1/20 0.34
CLK2 P49760 1/20 0.34
GSK3A P49840 1/20 0.34
GSK3B P49841 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8339628 0.81 SLC9A1 (0.46) SLC9A1HTR7HTR2B
SCHEMBL8339113 0.81 SLC9A1 (0.42) HTR5ASLC9A1KDM4EL3MBTL1
SCHEMBL6082100 0.81 ADORA2A (0.36) KDM4EL3MBTL1CDC7AURKAPRKD3
SCHEMBL8339462 0.78 HTR5A (0.44) HTR5ASLC9A1
SCHEMBL8346528 0.76 RORC (0.38) HTR5ASLC9A1KDM4EL3MBTL1AURKA
SCHEMBL8336852 0.73 MEN1 (0.46) MAPK1
SCHEMBL8340484 0.72 COMT (0.55) SLC9A1HTR7HTR2B
SCHEMBL25205591 0.68 PIK3R2 (0.38) KDM4EL3MBTL1CDC7AURKAPRKD3
SCHEMBL31095534 0.68 PIK3R2 (0.38) KDM4EL3MBTL1CDC7AURKAPRKD3
SCHEMBL8337393 0.67 NCF1 (0.45) HTR5ASLC9A1L3MBTL1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004007478-A2 DERIVATIVES OF 3-GUANIDINOCARBONYL-1-HETEROARYL-PYRROLE, PROCESS FOR THEIR PREPARATION AND THEIR PHARMACEUTICAL USE AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2004-01-22 WO disclosed